0
0

Patient Shared Savings Act

10/28/2022, 1:46 AM

Congressional Summary of S 3000

Patient Shared Savings Act

This bill allows a prescription drug plan (PDP) sponsor under the Medicare prescription drug benefit to share realized savings from an enrollee's switch to a lower-cost therapeutic alternative with the enrollee, in accordance with specified requirements. Among other requirements, the enrollee must have been taking the original prescription drug for at least two months and must have consulted with a physician before making the switch. PDP sponsors must share the savings in a tangible form that directly benefits the enrollee (e.g., a monetary rebate).

Current Status of Bill S 3000

Bill S 3000 is currently in the status of Bill Introduced since December 9, 2019. Bill S 3000 was introduced during Congress 116 and was introduced to the Senate on December 9, 2019.  Bill S 3000's most recent activity was Read twice and referred to the Committee on Finance. as of December 9, 2019

Bipartisan Support of Bill S 3000

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3000

Primary Policy Focus

Health

Potential Impact Areas

- Drug therapy
- Health care costs and insurance
- Medicare
- Prescription drugs

Alternate Title(s) of Bill S 3000

Patient Shared Savings Act
Patient Shared Savings Act
A bill to amend title XVIII of the Social Security Act to allow PDP sponsors of prescription drug plans and Medicare Advantage organizations offering MA-PD plans to share with enrollees a portion of savings from switching to lower cost therapeutic alternative medications.

Comments